NEO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

NeoGenomics Inc

NASDAQ | NEO

9.38

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$1.21B

Market Cap

-

P/E Ratio

-0.82

EPS

$19.11

52 Week High

$4.72

52 Week Low

HEALTHCARE

Sector

NEO Chart

Recent Chart
Price Action

NEO Technicals

Tags:

NEO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $290M
Total Revenue $661M
Cost Of Revenue $370M
Costof Goods And Services Sold $370M
Operating Income -$92M
Selling General And Administrative $226M
Research And Development $31M
Operating Expenses $382M
Investment Income Net -
Net Interest Income $12M
Interest Income $18M
Interest Expense $6.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $73M
Income Before Tax -$81M
Income Tax Expense -$1.9M
Interest And Debt Expense -
Net Income From Continuing Operations -$79M
Comprehensive Income Net Of Tax -
Ebit -$74M
Ebitda -$1.5M
Net Income -$79M

Revenue & Profitability

Earnings Performance

NEO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.6B
Total Current Assets $596M
Cash And Cash Equivalents At Carrying Value $367M
Cash And Short Term Investments $367M
Inventory $27M
Current Net Receivables $151M
Total Non Current Assets $1B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $340M
Intangible Assets Excluding Goodwill $340M
Goodwill $523M
Investments -
Long Term Investments -
Short Term Investments $20M
Other Current Assets $32M
Other Non Current Assets -
Total Liabilities $736M
Total Current Liabilities $301M
Current Accounts Payable $22M
Deferred Revenue -
Current Debt -
Short Term Debt $204M
Total Non Current Liabilities $434M
Capital Lease Obligations $64M
Long Term Debt $340M
Current Long Term Debt $201M
Long Term Debt Noncurrent -
Short Long Term Debt Total $605M
Other Current Liabilities $75M
Other Non Current Liabilities $12M
Total Shareholder Equity $902M
Treasury Stock -
Retained Earnings -$326M
Common Stock $128K
Common Stock Shares Outstanding $25M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $7M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $73M
Capital Expenditures $41M
Change In Receivables -
Change In Inventory -$2.7M
Profit Loss -
Cashflow From Investment $13M
Cashflow From Financing $4.6M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$79M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $290M
Total Revenue $661M
Cost Of Revenue $370M
Costof Goods And Services Sold $370M
Operating Income -$92M
Selling General And Administrative $226M
Research And Development $31M
Operating Expenses $382M
Investment Income Net -
Net Interest Income $12M
Interest Income $18M
Interest Expense $6.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $73M
Income Before Tax -$81M
Income Tax Expense -$1.9M
Interest And Debt Expense -
Net Income From Continuing Operations -$79M
Comprehensive Income Net Of Tax -
Ebit -$74M
Ebitda -$1.5M
Net Income -$79M

NEO News

NEO Profile

NeoGenomics Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

NeoGenomics, Inc. is a leading provider of cancer-focused diagnostics and testing services, operating an extensive network of laboratories across the United States, Europe, and Asia. Headquartered in Fort Myers, Florida, the company specializes in molecular and genomic testing, aiming to improve patient outcomes through innovative diagnostic solutions. With a commitment to advancing cancer care, NeoGenomics leverages cutting-edge technology and a robust portfolio of tests to support healthcare providers and patients in making informed treatment decisions.

VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+2.10%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.24%
$17.42
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
AQMS
+198.89%
$29.62
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
NB
+3.09%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
VHAI
+66.66%
$0.00
YYAI
-11.76%
$0.15
BURU
-20.39%
$0.40
UGRO
+54.52%
$0.57
NVDA
-4.40%
$180.03
CGBS
-39.47%
$0.03
PLUG
+6.26%
$4.14
BITF
+28.33%
$5.39
NVTS
+26.07%
$12.57
TMQ
+59.90%
$10.49
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.73%
$3.19
INTC
-4.27%
$35.63
LAES
+24.79%
$7.65
BYND
-23.22%
$0.79
JOBY
+8.05%
$18.12
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.05%
$0.34
F
+1.08%
$11.66
EDHL
+114.42%
$1.07
CRML
+28.73%
$29.97
WULF
+10.42%
$15.46
ACHR
+1.91%
$13.01
BBD
+2.10%
$3.15
SOUN
+8.98%
$20.86
NAK
+4.13%
$2.76
TLRY
-5.32%
$1.60
QBTS
+5.93%
$43.03
DVLT
+24.76%
$2.12
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
GPUS
-6.93%
$0.40
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
SOFI
+2.68%
$27.87
AXDX
-61.36%
$0.03
CLF
+0.83%
$13.94
QS
+15.57%
$16.98
ERIC
+20.56%
$9.85
RIG
-2.65%
$3.11
ETHD
+6.45%
$3.54
CIFR
+2.70%
$20.89
NIO
-5.15%
$6.81
QUBT
+1.49%
$21.78
NUAI
+30.63%
$3.07
UAMY
+4.24%
$17.42
ASST
-7.69%
$0.99
NOK
+4.28%
$5.47
CLSK
+9.68%
$21.98
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
IREN
+8.16%
$69.37
AREC
+36.74%
$6.81
ABAT
+36.59%
$9.22
RF
+2.44%
$25.16
BTG
+0.56%
$5.34
KDLY
-1.56%
$0.85
AAL
+1.90%
$11.74
USAR
-2.72%
$37.62
UUUU
+16.86%
$23.77
PFE
-0.82%
$24.52
BAC
+2.45%
$50.06
SNAP
-1.61%
$7.92
BMNR
-6.84%
$52.96
RMBL
+60.50%
$3.21
MP
+3.78%
$98.66
ADAP
-2.59%
$0.18
AMZN
-1.69%
$216.34
T
+2.11%
$26.13
ADD
-25.47%
$0.05
JBLU
+7.91%
$4.91
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.76%
$24.99
IONQ
-5.50%
$77.56
AQMS
+198.89%
$29.62
BCRX
-8.59%
$6.43
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDP
+2.32%
$26.42
GRAB
-0.33%
$5.91
RGTZ
-4.94%
$8.84
GWH
-15.91%
$7.61
BULL
-0.08%
$11.73
DFLI
-2.54%
$1.53
ABEV
+1.16%
$2.16
VALE
+2.41%
$11.01
NB
+3.09%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
GDXD
+3.16%
$0.75
FHN
+2.47%
$23.00
WWR
+29.29%
$2.56
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.